LAGEVRIO 200 mg/1 (Molnupiravir CAPSULE) 200 mg/1

LAGEVRIO 200 mg capsules are an antiviral medication used to treat certain viral infections. This oral medication is designed to help manage symptoms and support recovery.

Strength

200 mg/1

Pack Size

40 CAPSULE in 1 BOTTLE, PLASTIC (0006-5055-09)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LAGEVRIO 200 mg capsules are primarily used for the treatment of viral infections. This medication is often prescribed to help alleviate symptoms and support the body's natural healing process. It is important to follow the guidance of a healthcare professional when considering the use of LAGEVRIO for viral infections.

Side Effects

Common effects of LAGEVRIO 200 mg capsules may include gastrointestinal discomfort, dizziness, and fatigue. Some individuals may experience mild to moderate side effects, which typically subside as the body adjusts to the medication.

Precautions & Warnings

LAGEVRIO 200 mg capsules should be handled with care and stored as directed. It is important to inform your healthcare provider about any existing medical conditions or allergies before starting this medication. Always follow the prescribed dosage and administration instructions.

Avoid Interactions

LAGEVRIO 200 mg capsules may interact with certain medications, including other antivirals and some over-the-counter drugs. It is advisable to consult a healthcare professional before combining LAGEVRIO with other medications or supplements.

Frequently Asked Questions

LAGEVRIO is used to treat certain viral infections, helping to manage symptoms and support recovery.

LAGEVRIO capsules are taken orally, typically with water. Follow the specific instructions provided by your healthcare professional.

Common side effects may include gastrointestinal discomfort, dizziness, and fatigue. These effects are usually mild and temporary.

LAGEVRIO may interact with other medications. Consult a healthcare professional before combining it with other drugs or supplements.

Store LAGEVRIO capsules in a cool, dry place, away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.